Bioequivalence and Bioavailability Forum 02:19 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

is Perindoprilat optional? [Regulatives / Guidelines]

posted by mittyri - Russia, 2018-05-17 22:47  - Posting: # 18779
Views: 862

Dear All,

could you please enlighten me what is the reason to analyse and describe PK of Perindoprilat when one of APIs is Perindopril (as an example)?
As EMA stated
Also for inactive prodrugs, demonstration of bioequivalence for parent compound is recommended.
The active metabolite does not need to be measured.


What is the reason why the experts could insist to include Perindoprilat to the list of analytes?

Kind regards,
Mittyri

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,697 posts in 3,982 threads, 1,232 registered users;
online 13 (0 registered, 13 guests [including 10 identified bots]).

I have had my results for a long time:
but I do not yet know how I am to arrive
at them.    Carl Friedrich Gauß

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed